Free Trial
→ A grave, grave error. (From Porter & Company) (Ad) Buy RVNC Stock  Free RVNC Stock Alerts

Revance Therapeutics (RVNC) SEC Filings & 10K Form

Revance Therapeutics logo
$3.65 0.00 (0.00%)
As of 02/6/2025
Compare

Recent Revance Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/15/2025
11:33 AM		Beryl Capital Management LLC (Filed by)
Revance Therapeutics (Subject)
Form SCHEDULE 13G/A
03/06/2025
9:52 AM		JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
Form SCHEDULE 13G/A
02/18/2025
5:07 AM		Revance Therapeutics (Filer)
Form 15-12G
02/12/2025
6:57 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
6:58 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
7:00 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
7:01 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
7:02 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
7:03 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
7:04 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
7:06 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
7:08 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
7:16 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
6:50 AM		Revance Therapeutics (Filer)
Form POSASR
02/12/2025
6:52 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
6:53 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
6:54 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/12/2025
6:55 AM		Revance Therapeutics (Filer)
Form S-8 POS
02/11/2025
11:16 AM		JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
Form SCHEDULE 13G
02/06/2025
7:06 PM		Gangolli Julian S (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
5:19 PM		GLAZER CAPITAL, LLC (Filed by)
Revance Therapeutics (Subject)
Form SCHEDULE 13G
02/06/2025
2:45 PM		Revance Therapeutics (Issuer)
Russell Angus C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
2:48 PM		Nolet Chris (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
2:49 PM		Beraud Jill (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
2:49 PM		Coric Vlad (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
8:22 AM		Nasdaq Stock Market LLC (Filed by)
Revance Therapeutics (Subject)
Form 25-NSE
02/06/2025
7:59 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
6:53 PM		Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:53 PM		Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:53 PM		Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
7:41 AM		Revance Therapeutics (Subject)
Form SC 14D9/A
02/05/2025
7:14 AM		Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC TO-T/A
01/31/2025
7:08 AM		Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC TO-T/A
01/31/2025
6:46 AM		Revance Therapeutics (Subject)
Form SC 14D9/A
01/30/2025
8:01 AM		Revance Therapeutics (Subject)
Teoxane SA (Filed by)
Form SCHEDULE 13D/A
01/21/2025
7:31 AM		Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC TO-T/A
01/21/2025
7:36 AM		Revance Therapeutics (Subject)
Form SC 14D9/A
01/21/2025
7:11 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
7:15 AM		Revance Therapeutics (Subject)
Form SC 14D9/A
01/13/2025
3:18 PM		Revance Therapeutics (Subject)
Form SC 14D9/A
01/13/2025
7:44 AM		Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC TO-T/A
Was $49. Now $7. (not for long) (Ad)

It was $49 to join our Money Monday Revolution… …a renegade group of traders defying the odds, and targeting a year’s worth of gains with just one trade every Monday at 9:30am… But right now, for a limited time… You can get access for just $7 today!

Join the Money Monday revolution now for just $7 today >>
01/10/2025
3:52 PM		Beryl Capital Management LLC (Filed by)
Revance Therapeutics (Subject)
Form SCHEDULE 13G
01/07/2025
8:02 PM		Revance Therapeutics (Subject)
Form SC 14D9/A
01/06/2025
8:00 AM		Revance Therapeutics (Subject)
Teoxane SA (Filed by)
Form SCHEDULE 13D/A
01/03/2025
3:33 PM		Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:34 PM		Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:36 PM		Revance Therapeutics (Subject)
Form SC 14D9/A
01/02/2025
3:45 PM		Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC TO-T/A
12/19/2024
8:00 AM		Revance Therapeutics (Subject)
Teoxane SA (Filed by)
Form SCHEDULE 13D/A
12/12/2024
7:01 AM		Revance Therapeutics (Subject)
Form SC 14D9
12/12/2024
6:15 AM		Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC TO-T
12/12/2024
5:01 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
4:16 PM		Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC TO-C
12/09/2024
8:24 AM		Revance Therapeutics (Subject)
Form SC14D9C
12/09/2024
8:17 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:23 PM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
7:27 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
5:02 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
5:01 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
8:24 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
12:20 PM		FRANKLIN RESOURCES INC (Filed by)
Revance Therapeutics (Subject)
Form SCHEDULE 13G/A
10/25/2024
7:49 PM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
6:17 PM		GIC Private Ltd (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
10/18/2024
8:29 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
9:08 AM		Capital World Investors (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
10/04/2024
6:32 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
6:15 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
4:01 PM		Beryl Capital Management LLC (Filed by)
Revance Therapeutics (Subject)
Form SC 13G
09/09/2024
9:40 AM		Capital World Investors (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
09/05/2024
4:27 PM		Revance Therapeutics (Subject)
Form SC14D9C
09/05/2024
3:45 PM		Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC TO-C
08/13/2024
8:29 AM		Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC TO-C
08/12/2024
4:18 PM		Revance Therapeutics (Subject)
Form SC14D9C
08/12/2024
8:20 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
8:00 AM		Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:34 PM		Revance Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/02/2024
4:47 PM		Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:47 PM		Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RVNC) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...
Behind the Markets | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...
Brownstone Research | Sponsored
Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
After Monday, price goes up 600% (hurry)
Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...
Timothy Sykes | Sponsored